P

Protagonist Therapeutics

D
PTGX
USD
1.2
(2.6846%)
Market Closed
28,499.00
Volume
1.44
EPS
-
Div Yield
16.835
P/E
2,703,720,451.50
Market Cap
Today
2.6846%
1 Week
0.548%
1 Month
9.599%
6 Months
59.264%
12 Months
159.762%
Year To Date
100.131%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ALLO
0.025
(0.8681%)
USD
C
CRVS
0.07
(1.275%)
USD
NVS
NVS
-0.02
(-0.0172%)
USD
G
GLYC
0.0044
(2.6667%)
USD
O
ONCY
0.0139
(1.4849%)
USD
PFE
PFE
-0.09
(-0.3025%)
USD
MRK
MRK
-1.44
(-1.2137%)
USD
BMY
BMY
-0.72
(-1.4475%)
USD
ABBV
ABBV
0.73
(0.3784%)
USD
GILD
GILD
0.015
(0.0179%)
USD

Title:
Protagonist Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.
Do you need help or have a question?
Contact Us